Keeley M. Cain Wettan - 04 Feb 2026 Form 3 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
EVP Gen Counsel, Legal & Comp
Signature
/s/ Edward S. Son by Power of Attorney for Keeley M. Cain Wettan
Issuer symbol
GILD
Transactions as of
04 Feb 2026
Net transactions value
$0
Form type
3
Filing time
12 Feb 2026, 19:26:43 UTC
Next filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp 333 LAKESIDE DRIVE, FOSTER CITY /s/ Edward S. Son by Power of Attorney for Keeley M. Cain Wettan 12 Feb 2026 0002110603

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GILD Common Stock 3,944 04 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GILD Restricted Stock Unit 04 Feb 2026 Common Stock 5,440 Direct F1, F2
holding GILD Restricted Stock Unit 04 Feb 2026 Common Stock 11,342 Direct F2, F3
holding GILD Non-qualified Stock Option (Right to Buy) 04 Feb 2026 Common Stock 3,072 $57.92 Direct F4
holding GILD Non-qualified Stock Option (Right to Buy) 04 Feb 2026 Common Stock 4,412 $79.50 Direct F4
holding GILD Non-qualified Stock Option (Right to Buy) 04 Feb 2026 Common Stock 6,996 $75.12 Direct F4
holding GILD Non-qualified Stock Option (Right to Buy) 04 Feb 2026 Common Stock 5,140 $117.21 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance vest 6.25% quarterly thereafter until fully vested.
F2 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F3 The restricted stock units have a three-year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested.
F4 The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance vest 6.25% quarterly thereafter until fully vested.